DaVita Inc

DVA: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
$lWLOCK|K!xzTLOCK|Ftl@&>

DaVita Earnings: Keeps 2025 Guidance Roughly Intact Despite Ongoing Volume and Margin Challenges

In the third quarter, dialysis service provider DaVita grew revenue by 5%, but its adjusted EPS declined 3% year over year, despite major share repurchase activities in recent months. The company kept its 2025 roughly guidance intact, though, just narrowing some ranges.

Sponsor Center